2025 Q3 -tulosraportti
82 päivää sitten54 min
3,75 DKK/osake
Viimeisin osinko
2,93%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 306 200
Myynti
Määrä
1 303 966
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 400 | - | - | ||
| 595 | - | - | ||
| 1 936 | - | - | ||
| 450 | - | - | ||
| 2 000 | - | - |
Ylin
404,35VWAP
Alin
390,4VaihtoMäärä
1 644,7 4 151 867
VWAP
Ylin
404,35Alin
390,4VaihtoMäärä
1 644,7 4 151 867
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. |
| Menneet tapahtumat | ||
|---|---|---|
| Ylimääräinen yhtiökokous 2025 | 14.11.2025 | |
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 7.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 27.3.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 t sittenMette F.'s mackerel check should definitely be put into Novo shares and good red wine. What will you spend the money on? 😅
·2 t sittenNot a single word about the free trade agreement with India here on the tiktok daytrader blog? 😊 It's a hugely exciting market that can be opened up here, with the tariff advantage over Lilly's US/India agreement. There will be a large volume demand from the Indian middle class for weight loss products. And diabetes is a huge health problem in India, where the Indian population is much more exposed to getting diabetes than many other countries. FDA has postponed a possible approval of Lilly's pill until April 10, as there (rumors say) has arisen doubt about data and the analysis of the increasing liver enzymes in the phase 3 study. Likewise, there are reports of doubt about the high dropout percentage. Which may be a doubt about whether the preparation is actually beneficial for overweight people, if patents are not able to complete the weight loss. Is it true that Pfizer dropped their preparation already in phase 2, as it precisely showed the problem with liver enzymes, and that they could not see a way out of it, or had the finances for it? Are there any smart people who can tell what can be expected regarding India and the market there? Or are there any who keep updated on Lilly's FDA application, and what the FDA is looking into?
·1 t sittenNo worries - the average Dane will soon automatically and tax-free receive several thousand kroner in 'grease money'; partly to ensure that no overweight Danes go to bed hungry and emaciated and partly to secure jobs in the unholy alliance between the health and fast-food industries. The handout has absolutely nothing to do with getting motherly Mette and grumpy Lars re-elected.
·4 t sittenI have supplemented my pharma/biotech portfolio with Sprint Bioscience, though only with a small amount. It looks like it will shoot upwards, but there are also risks. Do any of you have other good suggestions for small stocks within this sector?
·4 t sitten · MuokattuThat Trump's economic suicide will drag down European companies and stock markets is hopefully a temporary problem. The dollar is plummeting and all other Western countries are trying to find other trading partners. Hope that Novo's management has control over the surely stronger and stronger changes, now that the company is so exposed in the USA.
·56 min sittenA weak dollar strengthens US exports... hardly something the US is unhappy about - it's the battle they've had against the Yuan for many, many years, who can weaken their currency the most, and thereby keep their exports up... something China greatly needs. A weak dollar and strong Yuan mean that Americans buy less Chinese.
·35 min sittenHenrik. It's probably like peeing in your pants. The USA is deep in debt, and they are constantly incurring more debt, every day. The USA must pay interest and repay debt with a weaker and weaker dollar. At the same time, new government bonds must be issued, where those who are to lend will demand a much higher risk premium. It's a really nasty cocktail. At the same time, Trump wants to punish the rest of the world with tariffs for trading with them. The EU has just made free trade agreements with 2 billion people. Everyone can see where it's heading. The USA is isolating itself. But then they can trade with themselves. Trump should read some national economics. Possibly Caynes and Smith. He is completely lost. Isolating his country, while at the same time destroying it. The country's separation of powers is on the verge of collapse, and soon he will also be the central bank governor. He is doing everything to get rid of Colin Powell. So a better opportunity for export doesn't help much. The world wants to avoid imports from the USA.- ·5 t sittenRSI heading towards zero. Panic is total from the weak hands. 🤑
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
82 päivää sitten54 min
3,75 DKK/osake
Viimeisin osinko
2,93%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 t sittenMette F.'s mackerel check should definitely be put into Novo shares and good red wine. What will you spend the money on? 😅
- ·2 t sittenNot a single word about the free trade agreement with India here on the tiktok daytrader blog? 😊 It's a hugely exciting market that can be opened up here, with the tariff advantage over Lilly's US/India agreement. There will be a large volume demand from the Indian middle class for weight loss products. And diabetes is a huge health problem in India, where the Indian population is much more exposed to getting diabetes than many other countries. FDA has postponed a possible approval of Lilly's pill until April 10, as there (rumors say) has arisen doubt about data and the analysis of the increasing liver enzymes in the phase 3 study. Likewise, there are reports of doubt about the high dropout percentage. Which may be a doubt about whether the preparation is actually beneficial for overweight people, if patents are not able to complete the weight loss. Is it true that Pfizer dropped their preparation already in phase 2, as it precisely showed the problem with liver enzymes, and that they could not see a way out of it, or had the finances for it? Are there any smart people who can tell what can be expected regarding India and the market there? Or are there any who keep updated on Lilly's FDA application, and what the FDA is looking into?·1 t sittenNo worries - the average Dane will soon automatically and tax-free receive several thousand kroner in 'grease money'; partly to ensure that no overweight Danes go to bed hungry and emaciated and partly to secure jobs in the unholy alliance between the health and fast-food industries. The handout has absolutely nothing to do with getting motherly Mette and grumpy Lars re-elected.
- ·4 t sittenI have supplemented my pharma/biotech portfolio with Sprint Bioscience, though only with a small amount. It looks like it will shoot upwards, but there are also risks. Do any of you have other good suggestions for small stocks within this sector?
- ·4 t sitten · MuokattuThat Trump's economic suicide will drag down European companies and stock markets is hopefully a temporary problem. The dollar is plummeting and all other Western countries are trying to find other trading partners. Hope that Novo's management has control over the surely stronger and stronger changes, now that the company is so exposed in the USA.·56 min sittenA weak dollar strengthens US exports... hardly something the US is unhappy about - it's the battle they've had against the Yuan for many, many years, who can weaken their currency the most, and thereby keep their exports up... something China greatly needs. A weak dollar and strong Yuan mean that Americans buy less Chinese.·35 min sittenHenrik. It's probably like peeing in your pants. The USA is deep in debt, and they are constantly incurring more debt, every day. The USA must pay interest and repay debt with a weaker and weaker dollar. At the same time, new government bonds must be issued, where those who are to lend will demand a much higher risk premium. It's a really nasty cocktail. At the same time, Trump wants to punish the rest of the world with tariffs for trading with them. The EU has just made free trade agreements with 2 billion people. Everyone can see where it's heading. The USA is isolating itself. But then they can trade with themselves. Trump should read some national economics. Possibly Caynes and Smith. He is completely lost. Isolating his country, while at the same time destroying it. The country's separation of powers is on the verge of collapse, and soon he will also be the central bank governor. He is doing everything to get rid of Colin Powell. So a better opportunity for export doesn't help much. The world wants to avoid imports from the USA.
- ·5 t sittenRSI heading towards zero. Panic is total from the weak hands. 🤑
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 306 200
Myynti
Määrä
1 303 966
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 400 | - | - | ||
| 595 | - | - | ||
| 1 936 | - | - | ||
| 450 | - | - | ||
| 2 000 | - | - |
Ylin
404,35VWAP
Alin
390,4VaihtoMäärä
1 644,7 4 151 867
VWAP
Ylin
404,35Alin
390,4VaihtoMäärä
1 644,7 4 151 867
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. |
| Menneet tapahtumat | ||
|---|---|---|
| Ylimääräinen yhtiökokous 2025 | 14.11.2025 | |
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 7.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 27.3.2025 |
2025 Q3 -tulosraportti
82 päivää sitten54 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. |
| Menneet tapahtumat | ||
|---|---|---|
| Ylimääräinen yhtiökokous 2025 | 14.11.2025 | |
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 7.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 27.3.2025 |
3,75 DKK/osake
Viimeisin osinko
2,93%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 t sittenMette F.'s mackerel check should definitely be put into Novo shares and good red wine. What will you spend the money on? 😅
- ·2 t sittenNot a single word about the free trade agreement with India here on the tiktok daytrader blog? 😊 It's a hugely exciting market that can be opened up here, with the tariff advantage over Lilly's US/India agreement. There will be a large volume demand from the Indian middle class for weight loss products. And diabetes is a huge health problem in India, where the Indian population is much more exposed to getting diabetes than many other countries. FDA has postponed a possible approval of Lilly's pill until April 10, as there (rumors say) has arisen doubt about data and the analysis of the increasing liver enzymes in the phase 3 study. Likewise, there are reports of doubt about the high dropout percentage. Which may be a doubt about whether the preparation is actually beneficial for overweight people, if patents are not able to complete the weight loss. Is it true that Pfizer dropped their preparation already in phase 2, as it precisely showed the problem with liver enzymes, and that they could not see a way out of it, or had the finances for it? Are there any smart people who can tell what can be expected regarding India and the market there? Or are there any who keep updated on Lilly's FDA application, and what the FDA is looking into?·1 t sittenNo worries - the average Dane will soon automatically and tax-free receive several thousand kroner in 'grease money'; partly to ensure that no overweight Danes go to bed hungry and emaciated and partly to secure jobs in the unholy alliance between the health and fast-food industries. The handout has absolutely nothing to do with getting motherly Mette and grumpy Lars re-elected.
- ·4 t sittenI have supplemented my pharma/biotech portfolio with Sprint Bioscience, though only with a small amount. It looks like it will shoot upwards, but there are also risks. Do any of you have other good suggestions for small stocks within this sector?
- ·4 t sitten · MuokattuThat Trump's economic suicide will drag down European companies and stock markets is hopefully a temporary problem. The dollar is plummeting and all other Western countries are trying to find other trading partners. Hope that Novo's management has control over the surely stronger and stronger changes, now that the company is so exposed in the USA.·56 min sittenA weak dollar strengthens US exports... hardly something the US is unhappy about - it's the battle they've had against the Yuan for many, many years, who can weaken their currency the most, and thereby keep their exports up... something China greatly needs. A weak dollar and strong Yuan mean that Americans buy less Chinese.·35 min sittenHenrik. It's probably like peeing in your pants. The USA is deep in debt, and they are constantly incurring more debt, every day. The USA must pay interest and repay debt with a weaker and weaker dollar. At the same time, new government bonds must be issued, where those who are to lend will demand a much higher risk premium. It's a really nasty cocktail. At the same time, Trump wants to punish the rest of the world with tariffs for trading with them. The EU has just made free trade agreements with 2 billion people. Everyone can see where it's heading. The USA is isolating itself. But then they can trade with themselves. Trump should read some national economics. Possibly Caynes and Smith. He is completely lost. Isolating his country, while at the same time destroying it. The country's separation of powers is on the verge of collapse, and soon he will also be the central bank governor. He is doing everything to get rid of Colin Powell. So a better opportunity for export doesn't help much. The world wants to avoid imports from the USA.
- ·5 t sittenRSI heading towards zero. Panic is total from the weak hands. 🤑
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 306 200
Myynti
Määrä
1 303 966
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 400 | - | - | ||
| 595 | - | - | ||
| 1 936 | - | - | ||
| 450 | - | - | ||
| 2 000 | - | - |
Ylin
404,35VWAP
Alin
390,4VaihtoMäärä
1 644,7 4 151 867
VWAP
Ylin
404,35Alin
390,4VaihtoMäärä
1 644,7 4 151 867
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 151 867 | 4 151 867 | 0 | 0 |